NCT04387136View on ClinicalTrials.gov

Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 14, 2020

Primary Completion Date

February 4, 2021

Study Completion Date

February 4, 2021

Conditions
PainPain, AcuteAnesthesia
Interventions
DRUG

Sublingual Sufentanil

15-30 minutes prior to planned emergence from anesthesia patients will either receive 30 mcg of sublingual sufentanil dispensed by the anesthesia provider.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT04387136 - Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center | Biotech Hunter | Biotech Hunter